Motor Complications in Parkinson's Disease: Ten Year Follow-Up Study

被引:76
作者
Cabo Lopez, Iria [1 ,2 ]
Garcia Ruiz, Pedro J. [1 ,2 ]
Vazquez Fernandez del Pozo, Silvia [3 ]
Sanchez Bernardos, Vicenta [1 ]
机构
[1] Fdn Jimenez Diaz, Dept Neurol, E-28040 Madrid, Spain
[2] Univ Autonoma Madrid, E-28049 Madrid, Spain
[3] Fdn Jimenez Diaz, Dept Epidemiol, E-28040 Madrid, Spain
关键词
dyskinesias; motor complications; motor fluctuations; Parkinson's disease; prospective study; SYDNEY MULTICENTER; LEVODOPA; PROGRESSION; ROPINIROLE;
D O I
10.1002/mds.23219
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Parkinson's disease (PD) can be symptomatically controlled with standard treatments; however, after a few years, this response typically declines and most patients develop motor complications. We carried out a prospective practice-based study to evaluate the evolution appearance and evolution of motor complications in 64 de novo PD patients over 5 years and in 38 PD patients over 10 years. We studied untreated patients from initial assessment at basal conditions and evaluated every 6 months thereafter with treatment (levodopa versus other drugs). The follow-up assessments were performed with the Unified Parkinson's Disease Rating Scale (UPDRS). At each assessment, patients were monitored regarding the development of dyskinesias, motor fluctuations, freezing, loss of postural reflexes, and cognitive impairment. We observed a significant improvement in UPDRS scores during the first year, then a progressive decline, more evident after the third year. Motor complications increased after the third year, and at the end of the survey (tenth year); drug-induced dyskinesias and motor fluctuations were experienced (71.1 and 94.7%, respectively). After the first decade, many complications arose from the non-levodopa-responsive features of the disease (cognitive impairment was present in 52.6% and gait freezing in 71.1%). Initial medication may influence medium-term complications but not long-term problems. Most long-term disabling problems of PD were related to non-levodoparesponsive features. (C) 2010 Movement Disorder Society
引用
收藏
页码:2735 / 2739
页数:5
相关论文
共 21 条
[1]   I can't get no satisfaction - Still no neuroprotection for Parkinson disease [J].
Ahlskog, J. Eric .
NEUROLOGY, 2007, 69 (15) :1476-1477
[2]   Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature [J].
Ahlskog, JE ;
Muenter, MD .
MOVEMENT DISORDERS, 2001, 16 (03) :448-458
[3]  
BARBEAU A, 1969, CAN MED ASSOC J, V101, P791
[4]  
Fahn S, 2004, NEW ENGL J MED, V351, P2498
[5]   Levodopa-related motor complications - Phenomenology [J].
Fox, Susan H. ;
Lang, Anthony E. .
MOVEMENT DISORDERS, 2008, 23 :S509-S514
[6]   Quality of Life in Early Parkinson's Disease Treated with Levodopa/Carbidopa/Entacapone [J].
Fung, Victor S. C. ;
Herawati, Lilie ;
Wan, Ying .
MOVEMENT DISORDERS, 2009, 24 (01) :25-31
[7]   Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa [J].
Hauser, Robert A. ;
Rascol, Olivier ;
Korczyn, Amos D. ;
Stoessl, A. Jon ;
Watts, Ray L. ;
Poewe, Werner ;
De Deyn, Peter P. ;
Lang, Anthony E. .
MOVEMENT DISORDERS, 2007, 22 (16) :2409-2417
[8]   Sydney multicenter study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years [J].
Hely, MA ;
Morris, JGL ;
Reid, WGJ ;
Trafficante, R .
MOVEMENT DISORDERS, 2005, 20 (02) :190-199
[9]   The Sydney multicentre study of Parkinson's disease: progression and mortality at 10 years [J].
Hely, MA ;
Morris, JGL ;
Traficante, R ;
Reid, WGJ ;
O'Sullivan, DJ ;
Williamson, PM .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1999, 67 (03) :300-307
[10]  
Holloway RG, 2004, ARCH NEUROL-CHICAGO, V61, P1044